nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—Prednisone—psoriatic arthritis	0.129	0.171	CbGbCtD
Tolterodine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.103	0.137	CbGbCtD
Tolterodine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0807	0.107	CbGbCtD
Tolterodine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0781	0.104	CbGbCtD
Tolterodine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0671	0.0889	CbGbCtD
Tolterodine—CYP3A4—Betamethasone—psoriatic arthritis	0.067	0.0889	CbGbCtD
Tolterodine—CYP3A4—Prednisolone—psoriatic arthritis	0.0661	0.0877	CbGbCtD
Tolterodine—CYP3A4—Prednisone—psoriatic arthritis	0.0625	0.0828	CbGbCtD
Tolterodine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0613	0.0813	CbGbCtD
Tolterodine—CYP3A4—Dexamethasone—psoriatic arthritis	0.039	0.0517	CbGbCtD
Tolterodine—Dementia—Prednisone—psoriatic arthritis	0.00671	0.0273	CcSEcCtD
Tolterodine—Visual impairment—Auranofin—psoriatic arthritis	0.00575	0.0234	CcSEcCtD
Tolterodine—Dementia—Methotrexate—psoriatic arthritis	0.00561	0.0228	CcSEcCtD
Tolterodine—Flatulence—Auranofin—psoriatic arthritis	0.00512	0.0208	CcSEcCtD
Tolterodine—Delusion—Methylprednisolone—psoriatic arthritis	0.00491	0.02	CcSEcCtD
Tolterodine—Angioedema—Auranofin—psoriatic arthritis	0.00475	0.0193	CcSEcCtD
Tolterodine—Delusion—Betamethasone—psoriatic arthritis	0.00447	0.0182	CcSEcCtD
Tolterodine—Delusion—Dexamethasone—psoriatic arthritis	0.00447	0.0182	CcSEcCtD
Tolterodine—Delusion—Prednisone—psoriatic arthritis	0.00389	0.0158	CcSEcCtD
Tolterodine—Dyspepsia—Auranofin—psoriatic arthritis	0.00373	0.0152	CcSEcCtD
Tolterodine—Constipation—Auranofin—psoriatic arthritis	0.00363	0.0148	CcSEcCtD
Tolterodine—Memory impairment—Prednisone—psoriatic arthritis	0.00351	0.0143	CcSEcCtD
Tolterodine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00347	0.0141	CcSEcCtD
Tolterodine—Abdominal pain—Auranofin—psoriatic arthritis	0.00335	0.0136	CcSEcCtD
Tolterodine—Dry eye—Dexamethasone—psoriatic arthritis	0.00292	0.0119	CcSEcCtD
Tolterodine—Dry eye—Betamethasone—psoriatic arthritis	0.00292	0.0119	CcSEcCtD
Tolterodine—Diarrhoea—Auranofin—psoriatic arthritis	0.0029	0.0118	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.00284	0.0116	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00261	0.0106	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00261	0.0106	CcSEcCtD
Tolterodine—Dry skin—Prednisolone—psoriatic arthritis	0.00252	0.0103	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00237	0.00965	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00237	0.00965	CcSEcCtD
Tolterodine—Weight increased—Prednisolone—psoriatic arthritis	0.00216	0.0088	CcSEcCtD
Tolterodine—Dry skin—Betamethasone—psoriatic arthritis	0.0021	0.00856	CcSEcCtD
Tolterodine—Dry skin—Dexamethasone—psoriatic arthritis	0.0021	0.00856	CcSEcCtD
Tolterodine—Bronchitis—Triamcinolone—psoriatic arthritis	0.0021	0.00855	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00203	0.00827	CcSEcCtD
Tolterodine—Weight increased—Triamcinolone—psoriatic arthritis	0.00199	0.00809	CcSEcCtD
Tolterodine—Weight increased—Methylprednisolone—psoriatic arthritis	0.00199	0.00808	CcSEcCtD
Tolterodine—Visual impairment—Prednisolone—psoriatic arthritis	0.00183	0.00746	CcSEcCtD
Tolterodine—Dry skin—Prednisone—psoriatic arthritis	0.00183	0.00745	CcSEcCtD
Tolterodine—Weight increased—Betamethasone—psoriatic arthritis	0.00181	0.00734	CcSEcCtD
Tolterodine—Weight increased—Dexamethasone—psoriatic arthritis	0.00181	0.00734	CcSEcCtD
Tolterodine—Hallucination—Methylprednisolone—psoriatic arthritis	0.00174	0.00707	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00173	0.00702	CcSEcCtD
Tolterodine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00168	0.00684	CcSEcCtD
Tolterodine—Hallucination—Dexamethasone—psoriatic arthritis	0.00158	0.00643	CcSEcCtD
Tolterodine—Hallucination—Betamethasone—psoriatic arthritis	0.00158	0.00643	CcSEcCtD
Tolterodine—Weight increased—Prednisone—psoriatic arthritis	0.00157	0.0064	CcSEcCtD
Tolterodine—Visual impairment—Dexamethasone—psoriatic arthritis	0.00153	0.00622	CcSEcCtD
Tolterodine—Visual impairment—Betamethasone—psoriatic arthritis	0.00153	0.00622	CcSEcCtD
Tolterodine—Angioedema—Prednisolone—psoriatic arthritis	0.00151	0.00616	CcSEcCtD
Tolterodine—Vertigo—Prednisolone—psoriatic arthritis	0.00149	0.00605	CcSEcCtD
Tolterodine—Angioedema—Triamcinolone—psoriatic arthritis	0.00139	0.00566	CcSEcCtD
Tolterodine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00139	0.00565	CcSEcCtD
Tolterodine—Hallucination—Prednisone—psoriatic arthritis	0.00138	0.0056	CcSEcCtD
Tolterodine—Vertigo—Triamcinolone—psoriatic arthritis	0.00137	0.00557	CcSEcCtD
Tolterodine—Vertigo—Methylprednisolone—psoriatic arthritis	0.00137	0.00556	CcSEcCtD
Tolterodine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00135	0.0055	CcSEcCtD
Tolterodine—Oedema—Prednisolone—psoriatic arthritis	0.00135	0.0055	CcSEcCtD
Tolterodine—Dysuria—Methotrexate—psoriatic arthritis	0.00135	0.00549	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00134	0.00546	CcSEcCtD
Tolterodine—Tachycardia—Prednisolone—psoriatic arthritis	0.00132	0.00537	CcSEcCtD
Tolterodine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00129	0.00526	CcSEcCtD
Tolterodine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00129	0.00525	CcSEcCtD
Tolterodine—Flushing—Prednisone—psoriatic arthritis	0.00128	0.00522	CcSEcCtD
Tolterodine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00127	0.00516	CcSEcCtD
Tolterodine—Angioedema—Dexamethasone—psoriatic arthritis	0.00126	0.00514	CcSEcCtD
Tolterodine—Angioedema—Betamethasone—psoriatic arthritis	0.00126	0.00514	CcSEcCtD
Tolterodine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00125	0.00509	CcSEcCtD
Tolterodine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00124	0.00506	CcSEcCtD
Tolterodine—Oedema—Triamcinolone—psoriatic arthritis	0.00124	0.00506	CcSEcCtD
Tolterodine—Vertigo—Betamethasone—psoriatic arthritis	0.00124	0.00505	CcSEcCtD
Tolterodine—Vertigo—Dexamethasone—psoriatic arthritis	0.00124	0.00505	CcSEcCtD
Tolterodine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00124	0.00505	CcSEcCtD
Tolterodine—Infection—Triamcinolone—psoriatic arthritis	0.00124	0.00502	CcSEcCtD
Tolterodine—Infection—Methylprednisolone—psoriatic arthritis	0.00123	0.00501	CcSEcCtD
Tolterodine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00121	0.00494	CcSEcCtD
Tolterodine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00121	0.00493	CcSEcCtD
Tolterodine—Anxiety—Dexamethasone—psoriatic arthritis	0.00117	0.00477	CcSEcCtD
Tolterodine—Anxiety—Betamethasone—psoriatic arthritis	0.00117	0.00477	CcSEcCtD
Tolterodine—Pain—Prednisolone—psoriatic arthritis	0.00116	0.0047	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00113	0.00461	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00113	0.0046	CcSEcCtD
Tolterodine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00113	0.00459	CcSEcCtD
Tolterodine—Oedema—Dexamethasone—psoriatic arthritis	0.00113	0.00459	CcSEcCtD
Tolterodine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00113	0.00459	CcSEcCtD
Tolterodine—Oedema—Betamethasone—psoriatic arthritis	0.00113	0.00459	CcSEcCtD
Tolterodine—Infection—Dexamethasone—psoriatic arthritis	0.00112	0.00456	CcSEcCtD
Tolterodine—Infection—Betamethasone—psoriatic arthritis	0.00112	0.00456	CcSEcCtD
Tolterodine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00111	0.00453	CcSEcCtD
Tolterodine—Visual impairment—Methotrexate—psoriatic arthritis	0.00111	0.00453	CcSEcCtD
Tolterodine—Tachycardia—Betamethasone—psoriatic arthritis	0.0011	0.00448	CcSEcCtD
Tolterodine—Tachycardia—Dexamethasone—psoriatic arthritis	0.0011	0.00448	CcSEcCtD
Tolterodine—Angioedema—Prednisone—psoriatic arthritis	0.0011	0.00447	CcSEcCtD
Tolterodine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00109	0.00445	CcSEcCtD
Tolterodine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00109	0.00444	CcSEcCtD
Tolterodine—Vertigo—Prednisone—psoriatic arthritis	0.00108	0.0044	CcSEcCtD
Tolterodine—Fatigue—Triamcinolone—psoriatic arthritis	0.00107	0.00436	CcSEcCtD
Tolterodine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00107	0.00435	CcSEcCtD
Tolterodine—Pain—Triamcinolone—psoriatic arthritis	0.00106	0.00432	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00103	0.00418	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00103	0.00418	CcSEcCtD
Tolterodine—Arthralgia—Prednisone—psoriatic arthritis	0.00103	0.00417	CcSEcCtD
Tolterodine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00102	0.00417	CcSEcCtD
Tolterodine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00102	0.00416	CcSEcCtD
Tolterodine—Anxiety—Prednisone—psoriatic arthritis	0.00102	0.00415	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00101	0.00413	CcSEcCtD
Tolterodine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000996	0.00405	CcSEcCtD
Tolterodine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000993	0.00404	CcSEcCtD
Tolterodine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000993	0.00404	CcSEcCtD
Tolterodine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000983	0.004	CcSEcCtD
Tolterodine—Oedema—Prednisone—psoriatic arthritis	0.000983	0.004	CcSEcCtD
Tolterodine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000981	0.00399	CcSEcCtD
Tolterodine—Infection—Prednisone—psoriatic arthritis	0.000976	0.00397	CcSEcCtD
Tolterodine—Fatigue—Betamethasone—psoriatic arthritis	0.000973	0.00396	CcSEcCtD
Tolterodine—Fatigue—Dexamethasone—psoriatic arthritis	0.000973	0.00396	CcSEcCtD
Tolterodine—Pain—Dexamethasone—psoriatic arthritis	0.000965	0.00392	CcSEcCtD
Tolterodine—Pain—Betamethasone—psoriatic arthritis	0.000965	0.00392	CcSEcCtD
Tolterodine—Tachycardia—Prednisone—psoriatic arthritis	0.000959	0.0039	CcSEcCtD
Tolterodine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00093	0.00378	CcSEcCtD
Tolterodine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00093	0.00378	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000923	0.00375	CcSEcCtD
Tolterodine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000923	0.00375	CcSEcCtD
Tolterodine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000916	0.00373	CcSEcCtD
Tolterodine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000914	0.00372	CcSEcCtD
Tolterodine—Vertigo—Methotrexate—psoriatic arthritis	0.000904	0.00368	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000895	0.00364	CcSEcCtD
Tolterodine—Dizziness—Prednisolone—psoriatic arthritis	0.000894	0.00364	CcSEcCtD
Tolterodine—Asthenia—Triamcinolone—psoriatic arthritis	0.000892	0.00363	CcSEcCtD
Tolterodine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000892	0.00363	CcSEcCtD
Tolterodine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000892	0.00363	CcSEcCtD
Tolterodine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00089	0.00362	CcSEcCtD
Tolterodine—Dyspepsia—Prednisone—psoriatic arthritis	0.000865	0.00352	CcSEcCtD
Tolterodine—Arthralgia—Methotrexate—psoriatic arthritis	0.000857	0.00348	CcSEcCtD
Tolterodine—Chest pain—Methotrexate—psoriatic arthritis	0.000857	0.00348	CcSEcCtD
Tolterodine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000849	0.00345	CcSEcCtD
Tolterodine—Fatigue—Prednisone—psoriatic arthritis	0.000847	0.00345	CcSEcCtD
Tolterodine—Headache—Prednisolone—psoriatic arthritis	0.000847	0.00345	CcSEcCtD
Tolterodine—Constipation—Prednisone—psoriatic arthritis	0.00084	0.00342	CcSEcCtD
Tolterodine—Confusional state—Methotrexate—psoriatic arthritis	0.000828	0.00337	CcSEcCtD
Tolterodine—Dizziness—Triamcinolone—psoriatic arthritis	0.000822	0.00334	CcSEcCtD
Tolterodine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000821	0.00334	CcSEcCtD
Tolterodine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000821	0.00334	CcSEcCtD
Tolterodine—Infection—Methotrexate—psoriatic arthritis	0.000816	0.00332	CcSEcCtD
Tolterodine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00081	0.00329	CcSEcCtD
Tolterodine—Asthenia—Betamethasone—psoriatic arthritis	0.00081	0.00329	CcSEcCtD
Tolterodine—Asthenia—Dexamethasone—psoriatic arthritis	0.00081	0.00329	CcSEcCtD
Tolterodine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000804	0.00327	CcSEcCtD
Tolterodine—Headache—Triamcinolone—psoriatic arthritis	0.000779	0.00317	CcSEcCtD
Tolterodine—Headache—Methylprednisolone—psoriatic arthritis	0.000777	0.00316	CcSEcCtD
Tolterodine—Abdominal pain—Prednisone—psoriatic arthritis	0.000777	0.00316	CcSEcCtD
Tolterodine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000772	0.00314	CcSEcCtD
Tolterodine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000772	0.00314	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000748	0.00304	CcSEcCtD
Tolterodine—Dizziness—Betamethasone—psoriatic arthritis	0.000746	0.00303	CcSEcCtD
Tolterodine—Dizziness—Dexamethasone—psoriatic arthritis	0.000746	0.00303	CcSEcCtD
Tolterodine—Somnolence—Methotrexate—psoriatic arthritis	0.00073	0.00297	CcSEcCtD
Tolterodine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000724	0.00294	CcSEcCtD
Tolterodine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000723	0.00294	CcSEcCtD
Tolterodine—Fatigue—Methotrexate—psoriatic arthritis	0.000708	0.00288	CcSEcCtD
Tolterodine—Headache—Dexamethasone—psoriatic arthritis	0.000707	0.00287	CcSEcCtD
Tolterodine—Headache—Betamethasone—psoriatic arthritis	0.000707	0.00287	CcSEcCtD
Tolterodine—Asthenia—Prednisone—psoriatic arthritis	0.000705	0.00287	CcSEcCtD
Tolterodine—Pain—Methotrexate—psoriatic arthritis	0.000702	0.00286	CcSEcCtD
Tolterodine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000677	0.00275	CcSEcCtD
Tolterodine—Diarrhoea—Prednisone—psoriatic arthritis	0.000672	0.00273	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000672	0.00273	CcSEcCtD
Tolterodine—Dizziness—Prednisone—psoriatic arthritis	0.00065	0.00264	CcSEcCtD
Tolterodine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000649	0.00264	CcSEcCtD
Tolterodine—Headache—Prednisone—psoriatic arthritis	0.000616	0.0025	CcSEcCtD
Tolterodine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000605	0.00246	CcSEcCtD
Tolterodine—Asthenia—Methotrexate—psoriatic arthritis	0.000589	0.0024	CcSEcCtD
Tolterodine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000562	0.00229	CcSEcCtD
Tolterodine—Dizziness—Methotrexate—psoriatic arthritis	0.000543	0.00221	CcSEcCtD
Tolterodine—Headache—Methotrexate—psoriatic arthritis	0.000515	0.00209	CcSEcCtD
